|
Market Closed -
Nasdaq
23:00:00 19/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.230 USD | +9.85% |
|
+7.73% | +62.77% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-13 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9.85% | +7.73% | +24.58% | +17.99% | +62.77% | +112.38% | -43.54% | -89.39% | - | 701M | |
| -1.90% | +3.12% | +39.11% | +61.12% | +80.94% | +81.70% | +110.88% | +25.43% | - | 73.45B | |
| +0.87% | +15.32% | +16.70% | +28.12% | +22.43% | +56.99% | +95.59% | +228.57% | +6,400.74% | 62.99B | |
| +1.71% | -1.22% | +20.62% | +21.65% | -24.93% | +2.71% | +501.29% | +481.75% | +928.01% | 28.05B | |
| +5.64% | +10.78% | +32.38% | +52.84% | +61.10% | +65.41% | +27.26% | -51.90% | - | 25.42B | |
| +21.96% | +21.98% | +23.66% | +28.85% | +18.82% | +1.54% | +2.50% | -65.91% | - | 23.3B | |
| +2.28% | +5.65% | +15.14% | +29.87% | +6.17% | +42.00% | -12.34% | -27.52% | +94.05% | 19.45B | |
| 0.00% | -2.78% | +17.15% | +95.10% | +230.42% | +247.46% | +423.83% | +1,773.26% | +857.44% | 18.16B | |
| +4.58% | +4.19% | +8.63% | +25.29% | +39.60% | +27.03% | +544.12% | - | - | 16.53B | |
| +2.39% | +7.96% | -2.74% | +11.75% | +24.09% | +44.96% | +157.77% | +205.73% | +394.45% | 13.16B | |
| +1.72% | +2.48% | +20.34% | +22.18% | +34.67% | +350.20% | +216.38% | +53.15% | +1,092.13% | 12.42B | |
| +3.01% | +0.74% | -2.41% | +5.54% | -7.24% | +42.32% | +200.52% | +585.66% | +5,726.97% | 12.12B | |
| +9.85% | -5.31% | +5.09% | -14.70% | -13.19% | -39.67% | +208.49% | +172.12% | - | 10.69B | |
| +2.16% | +2.78% | -3.04% | +1.69% | +22.35% | +105.44% | +139.64% | +159.13% | +560.49% | 10.58B | |
| +2.26% | -13.18% | -5.07% | -17.29% | -25.04% | -48.28% | +644.89% | +83.10% | +92.23% | 10.23B | |
| +1.02% | +4.64% | +8.67% | +63.49% | +232.48% | +576.10% | +789.14% | -37.85% | -15.57% | 9.51B | |
| +8.15% | +2.12% | +0.60% | -1.81% | +17.01% | +7.39% | +139.01% | -11.32% | - | 9.1B | |
| -0.04% | +0.27% | +0.99% | +142.39% | +81.93% | +187.77% | +424.72% | +297.61% | - | 8.99B | |
| +5.87% | +6.12% | +12.63% | +29.77% | +37.19% | +99.50% | +27.06% | +212.44% | - | 8.9B | |
| +5.31% | +5.04% | +5.86% | +4.77% | +310.61% | +256.58% | +349.17% | -11.34% | - | 8.18B | |
| Average | +4.10% | +1.90% | +11.95% | +30.43% | +60.61% | +110.98% | +247.32% | +209.62% | +1,613.10% | 19.1B | |
| Weighted average by Cap. | +2.95% | +4.40% | +18.48% | +36.59% | +52.70% | +86.59% | +205.74% | +211.78% | +2,753.34% |
- Stock Market
- Stocks
- ALLO Stock
- Sector Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
